tweenvest

Yarrow Bioscience, Inc. (NasdaqCM: YARW)

Health Care · Biotechnology · US

$19.63

+8.75% today · +6.3% 1Y

Public summary
A free snapshot of Yarrow Bioscience, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Yarrow Bioscience, Inc. (NasdaqCM: YARW) operates in the Biotechnology industry within the Health Care sector. The company is valued at $182.64M and employs 10 people.

Over the last twelve months the share price has gained 6.3%, trading between 13.60 and 46.95.

Tweenvest scores Yarrow Bioscience, Inc. across four factors: quality 77/100, value 80/100. Its strongest factor is value.

YARW price history

Nov 21, 2025 · 17.60Weekly closes 15.60 – 42.49Nov 12, 2026 · 19.63

Key figures

Market cap
$182.64M
Revenue (TTM)
—
P/E
-0.64
EPS
-66.82
Dividend yield
—
Beta (5Y)
2.13
52-week high
$46.95
52-week low
$13.60
Avg volume (3M)
—
Shares outstanding
9.30M
Employees
10
Next earnings
—

About Yarrow Bioscience, Inc.

Yarrow Bioscience is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The Company's lead product candidate, YB-101, is a potential first-in-class anti-thyroid stimulating hormone receptor (TSHR) monoclonal antibody designed to directly and rapidly disrupt the central mechanism of both Graves' disease (GD) and thyroid eye disease (TED).

ISIN
US92941V4077
Founded
2025
Listed since
Jul 28, 2026
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Artiva Biotherapeutics, Inc.NasdaqGM: ARTV$186.36M$3.92+3.95%
Entrada Therapeutics, Inc.NasdaqGM: TRDA$185.82M$5.09-1.55%
Anika Therapeutics, Inc.NasdaqGS: ANIK$184.99M$13.81-1.00%
Whitehawk Therapeutics, Inc.NasdaqCM: WHWK$184.70M$3.13+1.62%
TYK Medicines, IncSEHK: 2410$182.64MHK$3.73-9.15%
Thor Medical ASAOB: TRMED$179.44MNkr4.06-0.98%
Eledon Pharmaceuticals, Inc.NasdaqCM: ELDN$178.80M$2.12-10.57%
Healios K.K.TSE: 4593$178.72M¥210.00+1.94%

Browse every Biotechnology company →